Germany says production capacity, not patents, key to upping vaccine output

Germany says production capacity, not patents, key to upping vaccine output
Germany says production capacity, not patents, key to upping vaccine output Copyright (c) Copyright Thomson Reuters 2021. Click For Restrictions - https://agency.reuters.com/en/copyright.html
By Reuters
Share this articleComments
Share this articleClose Button

BERLIN (Reuters) - The main challenge to raising production of COVID-19 vaccines is how to quickly and effectively transfer technology, Germany's health minister said Friday, reiterating Berlin's opposition to a U.S. proposal to waive patent protection.

"The main issue is not patent protection but production capacity," Jens Spahn told a news conference on Friday.

In a jab at the Biden administration, Spahn also said: "I would be delighted if the United States shows the same willingness to export vaccines that we in Germany do."

(Reporting by Douglas Busvine and Paul Carrel, editing by Riham Alkousaa)

Share this articleComments

You might also like

Wife of Ukraine intelligence chief in hospital after 'heavy metal poisoning'

Estonia ready for 'migration spillover' after Finland closes border

Latest news bulletin | November 29th – Midday